XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Restructuring Charges, Net | 9 Months Ended
--- | ---
Jan. 29, 2016
Restructuring and Related Activities [Abstract] |
Restructuring Charges, Net | Restructuring Charges, Net Cost Synergies Initiative The cost synergies initiative, initially referred to as the fiscal year 2015 initiative, was the beginning of the Company's restructuring program primarily related to the acquisition of Covidien. This initiative is expected to contribute to the approximately $850 million in cost synergies expected to be achieved as a result of the Covidien acquisition through fiscal year 2018, including administrative office optimization, manufacturing and supply chain infrastructure, certain program cancellations, and certain general and administrative savings. Restructuring charges are expected to be incurred on a quarterly basis throughout fiscal year 2017 and in future fiscal years as cost synergy strategies are finalized. Restructuring accruals resulting from quarterly restructuring charges are scheduled to be substantially complete within one year from the quarter the restructuring charge was initially incurred. A summary of the activity related to the cost synergies initiative is presented below:
(in millions) | Employee Termination Costs |  | Asset Write-downs |  | Other Costs |  | Total
Balance as of April 24, 2015 | $ | 136 |  |  | $ | — |  |  | $ | 7 |  |  | $ | 143 |
Restructuring charges | 52 |  |  | — |  |  | 15 |  |  | 67 |
Payments/write-downs | (76 | ) |  | — |  |  | (7 | ) |  | (83 | )
Balance as of July 31, 2015 | $ | 112 |  |  | $ | — |  |  | $ | 15 |  |  | $ | 127 |
Restructuring charges | 64 |  |  | 10 |  |  | 12 |  |  | 86 |
Payments/write-downs | (28 | ) |  | (10 | ) |  | (6 | ) |  | (44 | )
Reversal of excess accrual | (13 | ) |  | — |  |  | — |  |  | (13 | )
Balance as of October 30, 2015 | $ | 135 |  |  | $ | — |  |  | $ | 21 |  |  | $ | 156 |
Restructuring charges | 36 |  |  | 12 |  |  | 7 |  |  | 55 |
Payments/write-downs | (30 | ) |  | (12 | ) |  | (8 | ) |  | (50 | )
Reversal of excess accrual | (17 | ) |  | — |  |  | (2 | ) |  | (19 | )
Balance as of January 29, 2016 | $ | 124 |  |  | $ | — |  |  | $ | 18 |  |  | $ | 142 |
As a result of certain employees identified for elimination finding other positions within the Company and revisions to severance provisions, the Company recorded a $19 million and a $32 million reversal of excess restructuring reserves for the three and nine months ended January 29, 2016, respectively. As part of the cost synergies initiative, the company recorded $12 million and $22 million of asset write-downs for the three and nine months ended January 29, 2016, respectively. For the three and nine months ended January 29, 2016, asset write-downs included $9 million related to inventory write-offs of discontinued product lines, and therefore, was recorded within cost of products sold in the consolidated statements of income. For the three and nine months ended January 29, 2016, asset write-downs included $3 million and $13 million related to property, plant, and equipment impairments, respectively. The Company did not record any significant impairments during the three months ended January 23, 2015. The Company recorded $10 million related to inventory write-offs of discontinued product lines and production-related asset impairments for the nine months ended January 23, 2015, and therefore, was recorded within cost of products sold in the condensed consolidated statements of earnings. Covidien Initiative Covidien's pre-acquisition restructuring program is designed to improve legacy Covidien's cost structure. The program consists of reducing corporate expenses, expanding shared services, consolidating manufacturing locations, and optimizing distribution centers. The Covidien restructuring initiative is scheduled to be substantially complete by the end of fiscal year 2018. At the Acquisition Date, the Company reserved $103 million in connection with the Covidien initiative, which consisted of employee termination costs of $76 million and other costs of $27 million. In the fourth quarter of fiscal year 2015, the Company recorded a reversal of excess restructuring reserves related to the Covidien initiative of $5 million. In addition, in the third quarter of fiscal year 2016, the Company recorded a reversal of excess restructuring reserves related to the Covidien initiative of $2 million. The reversals were primarily the result of certain employees identified for elimination finding other positions within the Company and revisions to particular strategies. A summary of the activity related to the Covidien initiative is presented below:
(in millions) | Employee Termination Costs |  | Other Costs |  | Total
Balance as of April 24, 2015 | $ | 61 |  |  | $ | 17 |  |  | $ | 78 |
Payments | (13 | ) |  | (5 | ) |  | (18 | )
Balance as of July 31, 2015 | $ | 48 |  |  | $ | 12 |  |  | $ | 60 |
Payments | (8 | ) |  | (6 | ) |  | (14 | )
Balance as of October 30, 2015 | $ | 40 |  |  | $ | 6 |  |  | $ | 46 |
Payments | (12 | ) |  | (2 | ) |  | (14 | )
Reversal of excess accrual | (2 | ) |  | — |  |  | (2 | )
Balance as of January 29, 2016 | $ | 26 |  |  | $ | 4 |  |  | $ | 30 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration